ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Clinical trial NCT06831799 · COMPLETED

Trial details

NCT number: NCT06831799
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Hemoglobinopathies Sickle Cell Disease Sickle Cell Anemia Sickle Beta Thalassemia Sickle-Cell; Hemoglobinopathy Sickle Cell Hemoglobin C Sickle Cell Hemoglobin D Sickle Cell-Hemoglobin E Disease Beta-Thalassemia Beta Thalassemia Major Beta Thalassemia Intermedia Dominant Beta-Thalassemia

Start date: 2020-04-15
Primary completion: 2023-06-30
Enrollment: 684

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.